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Characterization of nanoparticles and biologics is a critical step in the development of important new 
pharmaceutical products and biosimilars.  Biologics pose unique characterization challenges that require an 
interdisciplinary approach in which several orthogonal methods are used to provide a complete picture.  The 
physical characteristics of a biological product include properties such as the size, shape, morphology and 
aggregation state of the particles.  These properties are often dependent on the specific environment of the 
particles and thus ideally must be assessed under conditions that reflect the final formulation of the 
pharmaceutical.  Electron microscopy (EM) and in particular cryo-electron microscopy (cryoEM), has a unique 
advantage in that it provides a direct means of observing the individual particles in a sample, preserved in their 
natural hydrated state (cryoEM), simultaneously providing information on homogeneity, size distribution, titer, 
morphology, preservation state, flexibility, and aggregation state.  For particles with a regular size and shape, 
particle averaging methods can provide 3D structural information, complementing X-ray crystallography 
analysis.  
 
We will demonstrate the use of EM as an analytical and structural characterization tool by presenting a number 
of case studies as highlights.  Specifically, we will discuss the characterization of Human Papilloma Virus (HPV) 
VLPs in GARDASIL®, including the structure of the VLPs alone, on adjuvants, and when interacting with 
neutralizing antibodies [1].  We will also show how TEM was used as a non-intrusive tool to understand the 
structure and function of Hepatitis B surface antigen (rHBsAg) VLPs, the active component in the HBV vaccine 
[2].  We will furthermore demonstrate how TEM can be used to provide supporting information for 
characterization of a biosimilar drug delivery nanoparticle, a recombinant tuberculosis vaccine antigen, 
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